Adi Hoess, Founder of Affimed

Adi Hoess is the founder of Affimed. Affimed has raised $25M in total funding. Latest round: Series D. Based in Heidelberg, Germany.

About Adi Hoess

Adi Hoess is the CEO of Affimed, a therapeutic antibody company based in Heidelberg, Germany. Affimed develops unique antibody therapeutics, specifically TandAbs, for life-threatening diseases with high unmet medical needs. The company's pipeline includes drug candidates like AFM11 and AFM13, targeting CD19-positive and CD30-positive tumors respectively. Affimed recently closed a Series D financing round.

Adi Hoess at a glance

More founders in Heidelberg, Germany (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library